Back to Search Start Over

Dissolution Test Failure Prompts Recall of Anagrelide Capsules

Authors :
Duffy, Steve
Source :
MPR Monthly Prescribing Reference. May 27, 2022
Publication Year :
2022

Abstract

Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Anagrelide is indicated for the https://www.empr.com/drug/agrylin/, [...]

Subjects

Subjects :
Drug therapy
Product defects and recalls
Anagrelide

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.705085073

Tools

Authors Abstract Subjects Details